236 related articles for article (PubMed ID: 36727234)
1. [Noninvasive assessment of the risk of esophageal variceal bleeding from noncirrhotic portal hypertension].
Xu HF; Wang Y; He FL; Fan ZH; Liu H; Yang YP; Jia JD; Liu FQ; Ding HG
Zhonghua Gan Zang Bing Za Zhi; 2022 Oct; 30(10):1092-1099. PubMed ID: 36727234
[No Abstract] [Full Text] [Related]
2. Baveno VI and VII criteria are not suitable for screening for large varices or clinically significant portal hypertension in patients with hepatocellular carcinoma.
Allaire M; Campion B; Demory A; Larrey E; Wagner M; Rudler M; Roux C; Blaise L; Carrie NG; Thabut D
Aliment Pharmacol Ther; 2023 Aug; 58(3):346-356. PubMed ID: 37300315
[TBL] [Abstract][Full Text] [Related]
3. Risk assessment of esophageal variceal bleeding in B-viral liver cirrhosis by a liver stiffness measurement-based model.
Kim BK; Kim DY; Han KH; Park JY; Kim JK; Paik YH; Lee KS; Chon CY; Ahn SH
Am J Gastroenterol; 2011 Sep; 106(9):1654-62, 1730. PubMed ID: 21691339
[TBL] [Abstract][Full Text] [Related]
4. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease.
Colecchia A; Ravaioli F; Marasco G; Colli A; Dajti E; Di Biase AR; Bacchi Reggiani ML; Berzigotti A; Pinzani M; Festi D
J Hepatol; 2018 Aug; 69(2):308-317. PubMed ID: 29729368
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis.
Petta S; Sebastiani G; Bugianesi E; Viganò M; Wong VW; Berzigotti A; Fracanzani AL; Anstee QM; Marra F; Barbara M; Calvaruso V; Cammà C; Di Marco V; Craxì A; de Ledinghen V
J Hepatol; 2018 Oct; 69(4):878-885. PubMed ID: 29802949
[TBL] [Abstract][Full Text] [Related]
6. Spleen stiffness in patients with cirrhosis in predicting esophageal varices.
Sharma P; Kirnake V; Tyagi P; Bansal N; Singla V; Kumar A; Arora A
Am J Gastroenterol; 2013 Jul; 108(7):1101-7. PubMed ID: 23629600
[TBL] [Abstract][Full Text] [Related]
7. Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria.
Zhou H; Long J; Hu H; Tian CY; Lin SD
World J Gastroenterol; 2019 Sep; 25(35):5323-5333. PubMed ID: 31558876
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of non-invasive methods/models for predicting esophageal varices in patients with compensated advanced chronic liver disease secondary to nonalcoholic fatty liver disease.
Galizzi HO; Couto CA; Taranto DOL; Araújo SIO; Vilela EG
Ann Hepatol; 2021; 20():100229. PubMed ID: 32745630
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices.
Maurice JB; Brodkin E; Arnold F; Navaratnam A; Paine H; Khawar S; Dhar A; Patch D; O'Beirne J; Mookerjee R; Pinzani M; Tsochatzis E; Westbrook RH
J Hepatol; 2016 Nov; 65(5):899-905. PubMed ID: 27388923
[TBL] [Abstract][Full Text] [Related]
10. Baveno VI criteria and spleen stiffness measurement rule out high-risk varices in virally suppressed HBV-related cirrhosis.
Wang H; Wen B; Chang X; Wu Q; Wen W; Zhou F; Guo Y; Ji Y; Gu Y; Lai Q; He Q; Li J; Chen J; Hou J
J Hepatol; 2021 Mar; 74(3):584-592. PubMed ID: 33039403
[TBL] [Abstract][Full Text] [Related]
11. Course of oesophageal varices and performance of noninvasive predictors following Hepatitis C Virus clearance in compensated advanced chronic liver disease.
Giannini EG; De Maria C; Crespi M; Demarzo MG; Fazio V; Grasso A; Torre F; Bodini G; Marabotto E; Furnari M
Eur J Clin Invest; 2020 May; 50(5):e13231. PubMed ID: 32291753
[TBL] [Abstract][Full Text] [Related]
12. Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.
Thabut D; Bureau C; Layese R; Bourcier V; Hammouche M; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Goria O; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle-Bladou C; Dao T; Pilette C; Silvain C; Christidis C; Capron D; Bernard-Chabert B; Hillaire S; Di Martino V; Sutton A; Audureau E; Roudot-Thoraval F; Nahon P;
Gastroenterology; 2019 Mar; 156(4):997-1009.e5. PubMed ID: 30768988
[TBL] [Abstract][Full Text] [Related]
13. Validation of Baveno VI and Expanded-Baveno VI Criteria for predicting gastroesophageal varices in patients with alcoholic and non-alcoholic fatty liver disease.
Pizzamiglio M; Weicker A; de Terwangne C; Henrion J; Descamps OS; De Vos M
Acta Gastroenterol Belg; 2022; 85(2):321-329. PubMed ID: 35709776
[TBL] [Abstract][Full Text] [Related]
14. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis.
Berzigotti A; Seijo S; Arena U; Abraldes JG; Vizzutti F; García-Pagán JC; Pinzani M; Bosch J
Gastroenterology; 2013 Jan; 144(1):102-111.e1. PubMed ID: 23058320
[TBL] [Abstract][Full Text] [Related]
15. Prediction of the varices needing treatment with non-invasive tests in patients with compensated advanced chronic liver disease.
Lee HA; Kim SU; Seo YS; Lee YS; Kang SH; Jung YK; Kim MY; Kim JH; Kim SG; Suk KT; Jung SW; Jang JY; An H; Yim HJ; Um SH
Liver Int; 2019 Jun; 39(6):1071-1079. PubMed ID: 30589490
[TBL] [Abstract][Full Text] [Related]
16. A novel spleen-dedicated stiffness measurement by FibroScan® improves the screening of high-risk oesophageal varices.
Stefanescu H; Marasco G; Calès P; Fraquelli M; Rosselli M; Ganne-Carriè N; de Ledinghen V; Ravaioli F; Colecchia A; Rusu C; Andreone P; Mazzella G; Festi D
Liver Int; 2020 Jan; 40(1):175-185. PubMed ID: 31444849
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive model for predicting high-risk esophageal varices based on liver and spleen stiffness.
Yang LB; Gao X; Li H; Tantai XX; Chen FR; Dong L; Dang XS; Wei ZC; Liu CY; Wang Y
World J Gastroenterol; 2023 Jul; 29(25):4072-4084. PubMed ID: 37476583
[TBL] [Abstract][Full Text] [Related]
18. Baveno VI and Expanded Baveno VI criteria successfully predicts the absence of high-risk gastro-oesophageal varices in a Chilean cohort.
Gaete MI; Díaz LA; Arenas A; González K; Cattaneo M; Fuster F; Henríquez R; Soza A; Arrese M; Barrera F; Arab JP; Benítez C
Liver Int; 2020 Jun; 40(6):1427-1434. PubMed ID: 31916360
[TBL] [Abstract][Full Text] [Related]
19. Non-invasive diagnosis of esophageal varices after Baveno VI.
Moctezuma Velázquez C; Abraldes JG
Turk J Gastroenterol; 2017 May; 28(3):159-165. PubMed ID: 28492370
[TBL] [Abstract][Full Text] [Related]
20. Validation of original, expanded Baveno VI, and stepwise & platelet-MELD criteria to rule out varices needing treatment in compensated cirrhosis from various etiologies.
Nawalerspanya S; Sripongpun P; Chamroonkul N; Kongkamol C; Piratvisuth T
Ann Hepatol; 2020; 19(2):209-213. PubMed ID: 31607647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
